logo-loader
CSE:LOBE OTCQB:LOBEF

Lobe Sciences Ltd

Receive alerts
Market:
CSE
Price
0.02 CAD
Day Change
-
Market Cap:
$1.58 m
52 weeks high
0.04
52 weeks low
0.01

In brief

Lobe Sciences is a biopharmaceutical company focused on developing patient-friendly, practical psychedelic medicines. The Company, through collaborations with industry-leading partners, is engaged in drug research and development using sub-hallucinatory doses of psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness. Each of our New Chemical Entities, L-130 and L-131, are being developed to address unmet medical needs in neurological therapeutic applications.

Snapshot

  • Lobe Sciences says 2023 was 'transformative' as it made important advances
  • Lobe Sciences reaches milestone as it completes production of psilocin analogues